Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1984 Apr;81(4):589–597. doi: 10.1111/j.1476-5381.1984.tb16123.x

Effects of bepridil on the electrophysiological properties of guinea-pig ventricular muscles.

T Anno, T Furuta, M Itho, I Kodama, J Toyama, K Yamada
PMCID: PMC1986901  PMID: 6609738

Abstract

Effects of bepridil, a new antianginal and potential antiarrhythmic agent, on transmembrane action potentials of ventricular muscles were examined in isolated right ventricular papillary muscles of guinea-pig. Bepridil at concentrations above 5 X 10(-6)M caused a dose-dependent decrease in both the maximum upstroke velocity (Vmax) and the action potential duration from the upstroke to 30% repolarization ( APD30 ). On the other hand, the resting potential (RP), the amplitude of action potential (AMP), and the action potential duration from the upstroke to 90% repolarization ( APD90 ) were not affected even at the highest concentration applied (10(-5)M). The curves relating membrane potential and Vmax were shifted by bepridil at 5 X 10(-6)M along the voltage axis in the direction of more negative potentials. The recovery kinetics of Vmax assessed by premature stimuli were definitely slowed by bepridil at above 10(-6)M. This effect was more pronounced with higher [K+]o (10 mM) than normal [K+]o (5 mM). Bepridil at 5 X 10(-6)M caused a rate-dependent decrease of Vmax (use-dependent block) with rapid onset and offset, as did lidocaine. Slow responses, which had been induced by isoprenaline (5 X 10(-6)M) in K+-depolarized preparations, were suppressed significantly by additional application of bepridil at 10(-5)M. These findings suggest that bepridil has electrophysiological characteristics similar to those both of Class Ib and Class IV antiarrhythmic drugs.

Full text

PDF
589

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaughard M., Ferrier M., Labrid C., Lamar J. C., Leboeuf J., Piris P. Studies on the bradycardia induced by bepridil. Br J Pharmacol. 1982 Feb;75(2):293–300. doi: 10.1111/j.1476-5381.1982.tb08785.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Campbell T. J. Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification. Cardiovasc Res. 1983 Jun;17(6):344–352. doi: 10.1093/cvr/17.6.344. [DOI] [PubMed] [Google Scholar]
  3. Campbell T. J. Resting and rate-dependent depression of maximum rate of depolarisation (Vmax) in guinea pig ventricular action potentials by mexiletine, disopyramide, and encainide. J Cardiovasc Pharmacol. 1983 Mar-Apr;5(2):291–296. doi: 10.1097/00005344-198303000-00021. [DOI] [PubMed] [Google Scholar]
  4. Chen C. M., Gettes L. S., Katzung B. G. Effect of lidocaine and quinidine on steady-state characteristics and recovery kinetics of (dV/dt)max in guinea pig ventricular myocardium. Circ Res. 1975 Jul;37(1):20–29. doi: 10.1161/01.res.37.1.20. [DOI] [PubMed] [Google Scholar]
  5. Chen C., Gettes L. S. Combined effects of rate membrane potential, and drugs on maximum rate of rise (Vmax) of action potential upstroke of guinea pig papillary muscle. Circ Res. 1976 Jun;38(6):464–469. doi: 10.1161/01.res.38.6.464. [DOI] [PubMed] [Google Scholar]
  6. Cosnier D., Duchenne-Marullaz P., Rispat G., Streichenberger G. Cardiovascular pharmacology of bepridil (1[3 isobutoxy 2 (benzylphenyl) amino] propyl pyrrolidine hydrochloride) a new potential anti-anginal compound. Arch Int Pharmacodyn Ther. 1977 Jan;225(1):133–151. [PubMed] [Google Scholar]
  7. Courtney K. R. Interval-dependent effects of small antiarrhythmic drugs on excitability of guinea-pig myocardium. J Mol Cell Cardiol. 1980 Nov;12(11):1273–1286. doi: 10.1016/0022-2828(80)90071-1. [DOI] [PubMed] [Google Scholar]
  8. Courtney K. R. Structure-activity relations for frequency-dependent sodium channel block in nerve by local anesthetics. J Pharmacol Exp Ther. 1980 Apr;213(1):114–119. [PubMed] [Google Scholar]
  9. Gettes L. S., Reuter H. Slow recovery from inactivation of inward currents in mammalian myocardial fibres. J Physiol. 1974 Aug;240(3):703–724. doi: 10.1113/jphysiol.1974.sp010630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hauswirth O., Singh B. N. Ionic mechanisms in heart muscle in relation to the genesis and the pharmacological control of cardiac arrhythmias. Pharmacol Rev. 1978 Mar;30(1):5–63. [PubMed] [Google Scholar]
  11. Hohnloser S., Weirich J., Antoni H. Effects of mexiletine on steady-state characteristics and recovery kinetics of V max and conduction velocity in guinea pig myocardium. J Cardiovasc Pharmacol. 1982 Mar-Apr;4(2):232–239. doi: 10.1097/00005344-198203000-00011. [DOI] [PubMed] [Google Scholar]
  12. Hondeghem L. M., Katzung B. G. Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta. 1977 Nov 14;472(3-4):373–398. doi: 10.1016/0304-4157(77)90003-x. [DOI] [PubMed] [Google Scholar]
  13. Hondeghem L., Katzung B. G. Test of a model of antiarrhythmic drug action. Effects of quinidine and lidocaine on myocardial conduction. Circulation. 1980 Jun;61(6):1217–1224. doi: 10.1161/01.cir.61.6.1217. [DOI] [PubMed] [Google Scholar]
  14. Kane K. A., Winslow E. Antidysrhythmic and electrophysiological effects of a new antianginal agent, bepridil. J Cardiovasc Pharmacol. 1980;2(2):193–203. doi: 10.1097/00005344-198003000-00010. [DOI] [PubMed] [Google Scholar]
  15. Labrid C., Grosset A., Dureng G., Mironneau J., Duchene-Marullaz P. Some membrane interactions with bepridil, a new antianginal agent. J Pharmacol Exp Ther. 1979 Dec;211(3):546–554. [PubMed] [Google Scholar]
  16. Labrid C., Leinot M., Beaughard M., Basiez M., Duchene-Marullaz P. Comparative antidysrhythmic profiles of bepridil, amiodarone and disopyramide in the guinea-pig and dog. Arch Int Pharmacodyn Ther. 1981 Jan;249(1):87–97. [PubMed] [Google Scholar]
  17. Leinot M., Basiez M., Talvard J., Labrid C. Prolongation de la période réfractaire effective de l'oreillette isolée de cobaye par quelques antidysrythmiques: intérêt d'une comparaison de leurs potentialités. C R Seances Soc Biol Fil. 1979;173(4):773–780. [PubMed] [Google Scholar]
  18. Marshall R. J., Muir A. W. The beneficial actions of bepridil in acute myocardial infarction in anaesthetized dogs. Br J Pharmacol. 1981 Jun;73(2):471–479. doi: 10.1111/j.1476-5381.1981.tb10445.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Michelin M. T., Cheucle M., Duchene-Marullaz P. Influence comparée sur l'activité cardiaque et le débit veineux coronaire du bépridil, du dipyridamole et du propranolol chez le chien narcosé. Therapie. 1977 Jul-Aug;32(4):485–499. [PubMed] [Google Scholar]
  20. Piris P., Beaughard M., Cosnier D., Labrid C. Activity of bepridil and other anti-anginals on cardiovascular modifications engendered by conditioned anxiety in the dog. Arch Int Pharmacodyn Ther. 1978 Sep;235(1):147–164. [PubMed] [Google Scholar]
  21. Rosen M. R., Wit A. L., Hoffman B. F. Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil. Am Heart J. 1975 May;89(5):665–673. doi: 10.1016/0002-8703(75)90514-1. [DOI] [PubMed] [Google Scholar]
  22. Sada H., Ban T. Effects of various structurally related beta-adrenoceptor blocking agents on maximum upstroke velocity of action potential in guinea-pig papillary muscles. Naunyn Schmiedebergs Arch Pharmacol. 1981 Nov;317(3):245–251. doi: 10.1007/BF00503825. [DOI] [PubMed] [Google Scholar]
  23. Sada H., Kojima M., Ban T. Effect of procainamide on transmembrane action potentials in guinea-pig papillary muscles as affected by external potassium concentration. Naunyn Schmiedebergs Arch Pharmacol. 1979 Nov;309(2):179–190. doi: 10.1007/BF00501227. [DOI] [PubMed] [Google Scholar]
  24. Vogel S., Crampton R., Sperelakis N. Blockade of myocardial slow channels by bepridil (CERM-1978). J Pharmacol Exp Ther. 1979 Sep;210(3):378–385. [PubMed] [Google Scholar]
  25. Winslow E., Kane K. A. Supraventricular antidysrhythmic and electrophysiological effects of bepridil, a new antianginal agent. J Cardiovasc Pharmacol. 1981 Jul-Aug;3(4):655–667. doi: 10.1097/00005344-198107000-00001. [DOI] [PubMed] [Google Scholar]
  26. Wit A. L., Cranefield P. F. Effect of verapamil on the sinoatrial and atrioventricular nodes of the rabbit and the mechanism by which it arrests reentrant atrioventricular nodal tachycardia. Circ Res. 1974 Sep;35(3):413–425. doi: 10.1161/01.res.35.3.413. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES